| Genetic drug target validation using Mendelian randomisation AF Schmidt, C Finan, M Gordillo-Marañón, FW Asselbergs, DF Freitag, ... Nature communications 11 (1), 3255, 2020 | 361 | 2020 |
| Improving the odds of drug development success through human genomics: modelling study AD Hingorani, V Kuan, C Finan, FA Kruger, A Gaulton, S Chopade, ... Scientific reports 9 (1), 18911, 2019 | 227 | 2019 |
| Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study V Kuan, S Denaxas, P Patalay, D Nitsch, R Mathur, A Gonzalez-Izquierdo, ... The Lancet Digital Health 5 (1), e16-e27, 2023 | 93 | 2023 |
| Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney JM Eales, X Jiang, X Xu, S Saluja, A Akbarov, E Cano-Gamez, ... Nature Genetics 53 (5), 630-637, 2021 | 58 | 2021 |
| Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification M Kavousi, MM Bos, HJ Barnes, CL Lino Cardenas, D Wong, H Lu, ... Nature genetics 55 (10), 1651-1664, 2023 | 50 | 2023 |
| Genome-wide association meta-analysis of spontaneous coronary artery dissection identifies risk variants and genes related to artery integrity and tissue-mediated coagulation D Adlam, TE Berrandou, A Georges, CP Nelson, E Giannoulatou, J Henry, ... Nature Genetics 55 (6), 964-972, 2023 | 43 | 2023 |
| Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics M Gordillo-Marañón, M Zwierzyna, P Charoen, F Drenos, S Chopade, ... Nature communications 12 (1), 6120, 2021 | 24 | 2021 |
| Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity AF Schmidt, M Bourfiss, A Alasiri, E Puyol-Anton, S Chopade, M van Vugt, ... Science advances 9 (17), eadd4984, 2023 | 19 | 2023 |
| Comparing the effects of CETP in East Asian and European ancestries: a Mendelian randomization study D Dunca, S Chopade, M Gordillo-Marañón, AD Hingorani, ... Nature Communications 15 (1), 5302, 2024 | 7 | 2024 |
| Improving the odds of drug development success through human genomics: modelling study. Sci Rep A Hingorani, V Kuan, C Finan, F Kruger, A Gaulton, S Chopade, R Sofat, ... | 6 | 2019 |
| Impact of chromosomal heteromorphisms on recurrent miscarriages S Chopade, DK Chopade, H Harde Hum Genet Embryol 2, 101, 2012 | 6 | 2012 |
| Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study MM Almramhi, C Finan, CS Storm, AF Schmidt, DA Kia, R Coneys, ... Neurology 101 (17), e1729-e1740, 2023 | 5 | 2023 |
| Mapping the aetiological foundations of the heart failure spectrum using human genetics A Henry, X Mo, C Finan, MD Chaffin, D Speed, H Issa, S Denaxas, ... medRxiv, 2023.10. 01.23296379, 2023 | 5 | 2023 |
| Unexpected Inheritance of a Balanced Homologous translocation t (22q; 22q) from father to a phenotypically normal daughter DK Chopade, H Harde, P Ugale, S Chopade Indian Journal of Human Genetics 20 (1), 85, 2014 | 5 | 2014 |
| Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation M van Vugt, C Finan, S Chopade, R Providencia, CR Bezzina, ... Genome Medicine 16 (1), 120, 2024 | 3 | 2024 |
| Reproductive Outcomes in 101 Couples with Balanced Chromosomal Rearrangements D Chopade, S Gangane, S Chopade, H Harde Human Genet Embryol 8 (2), 150, 2018 | 3 | 2018 |
| Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders AF Schmidt, C Finan, S Chopade, S Ellmerich, MN Rossor, AD Hingorani, ... Open Biology 14 (7), 230419, 2024 | 2 | 2024 |
| Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders AF Schmidt, C Finan, S Chopade, S Ellmerich, MN Rossor, AD Hingorani, ... medRxiv, 2023 | 2 | 2023 |
| Druggable proteins influencing cardiac structure and function: implications for heart failure therapies and cancer related cardiotoxicity A Schmidt, M Bourfiss, A Alasiri, S Chopade, E Puyol-Anton, M van Vugt, ... | 2 | 2022 |
| New drug repurposing opportunities for hypertension uncovered by the convergence of genomics with kidney transcriptomics and epigenomics S Saluja, X Jiang, C Finan, S Chopade, J Eales, X Xu, NJ Samani, ... Circulation 140 (Suppl_1), A14286-A14286, 2019 | 2 | 2019 |
Aroon HingoraniUniversity College LondonΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ucl.ac.uk
